Literature DB >> 16448385

Size of myocardial infarction induced by ischaemia/reperfusion is unaltered in rats with metabolic syndrome.

Troels Thim1, Jacob F Bentzon, Steen B Kristiansen, Ulf Simonsen, Heidi L Andersen, Karsten Wassermann, Erling Falk.   

Abstract

Obesity is associated with metabolic syndrome and increased incidence of and mortality from myocardial infarction. The aim of the present study was to develop an animal model with metabolic syndrome and examine how that influences size of myocardial infarcts induced by occlusion and reperfusion of the left anterior descending coronary artery. Sprague-Dawley rats (n = 105) were fed either LF (low-fat) or MHF (moderately high-fat) diets for 13 weeks before coronary occlusion for 45 min, followed by reperfusion for 60 min. Compared with LF-fed and lean MHF-fed rats, obese MHF-fed rats developed metabolic disturbances similar to those seen in the metabolic syndrome, including being overweight by 24% (compared with lean MHF-fed rats), having 74% more visceral fat (compared with LF-fed rats), 15% higher blood pressure (compared with LF-fed rats), 116% higher plasma insulin (compared with lean MHF-fed rats), 10% higher fasting plasma glucose (compared with LF-fed rats), 35% higher non-fasting plasma glucose (compared with lean MHF-fed rats), 36% higher plasma leptin (compared with lean MHF-fed rats) and a tendency to lower plasma adiponectin and higher plasma non-esterified fatty acids. Infarct size was similar in the three groups of rats (36+/-14, 42+/-18 and 41+/-14% in obese MHF-fed, lean MHF-fed and LF-fed rats respectively). In conclusion, rats fed a MHF diet developed metabolic syndrome, but this did not influence myocardial infarct size.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16448385     DOI: 10.1042/CS20050326

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  9 in total

1.  Impaired contractile recovery after low-flow myocardial ischemia in a porcine model of metabolic syndrome.

Authors:  Janice V Huang; Li Lu; Shuyu Ye; Bryan C Bergman; Genevieve C Sparagna; Mohammad Sarraf; Jane E B Reusch; Clifford R Greyson; Gregory G Schwartz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-01-18       Impact factor: 4.733

2.  Effect of hypercholesterolemia on myocardial necrosis and apoptosis in the setting of ischemia-reperfusion.

Authors:  Robert M Osipov; Cesario Bianchi; Jun Feng; Richard T Clements; Yuhong Liu; Michael P Robich; Hilary P Glazer; Neel R Sodha; Frank W Sellke
Journal:  Circulation       Date:  2009-09-15       Impact factor: 29.690

Review 3.  Protection of the abnormal heart.

Authors:  Constantinos Pantos; Iordanis Mourouzis; Dennis V Cokkinos
Journal:  Heart Fail Rev       Date:  2007-12       Impact factor: 4.214

4.  Imaging of VEGF receptor in a rat myocardial infarction model using PET.

Authors:  Martin Rodriguez-Porcel; Weibo Cai; Olivier Gheysens; Jürgen K Willmann; Kai Chen; Hui Wang; Ian Y Chen; Lina He; Joseph C Wu; Zi-bo Li; Khalid A Mohamedali; Sehoon Kim; Michael G Rosenblum; Xiaoyuan Chen; Sanjiv Sam Gambhir
Journal:  J Nucl Med       Date:  2008-04       Impact factor: 10.057

Review 5.  Cardiac remodeling in obesity.

Authors:  E Dale Abel; Sheldon E Litwin; Gary Sweeney
Journal:  Physiol Rev       Date:  2008-04       Impact factor: 37.312

Review 6.  Myocardial protection in man--from research concept to clinical practice.

Authors:  Dennis V Cokkinos; Costas Pantos
Journal:  Heart Fail Rev       Date:  2007-12       Impact factor: 4.214

Review 7.  Diabetic cardiomyopathy: pathophysiology and clinical features.

Authors:  Takayuki Miki; Satoshi Yuda; Hidemichi Kouzu; Tetsuji Miura
Journal:  Heart Fail Rev       Date:  2013-03       Impact factor: 4.214

8.  Reducing Caloric Intake Prevents Ischemic Injury and Myocardial Dysfunction and Affects Anesthetic Cardioprotection in Type 2 Diabetic Rats.

Authors:  Charissa E van den Brom; Christa Boer; Rob F P van den Akker; Stephan A Loer; R Arthur Bouwman
Journal:  J Diabetes Res       Date:  2017-02-28       Impact factor: 4.011

9.  Novel insights into the cardio-protective effects of FGF21 in lean and obese rat hearts.

Authors:  Vanlata Patel; Raghu Adya; Jing Chen; Manjunath Ramanjaneya; Muhammad F Bari; Sunil K Bhudia; Edward W Hillhouse; Bee K Tan; Harpal S Randeva
Journal:  PLoS One       Date:  2014-02-03       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.